Contact
← All workflows

Quality Agreement for Contract Manufacturing

Draft FDA-Compliant Quality Agreements in Minutes

12 minutes with CaseMark

Fast lane

We have it from here.

Choose the fast one-off run here, or jump into the workspace when you want saved history, revisions, and a fuller matter workflow.

Run this once here

Best for a quick one-off job. Add your email, upload the files, and we'll run the workflow and send the result to your inbox.

1. Add your email so we know where to send the result.

2. Upload the files you want analyzed.

3. Run the workflow and we'll take it from there.

Use in Workspace

Best for ongoing matters

Save and reopen matters, keep documents together, refine the output, rerun with changes, and export or share polished work product when you're done.

Open in Workspace

Need more context?

Scroll for the workflow details below if you want to review what this run handles, what documents help, and what the output looks like.

If this is part of a live matter, the workspace is the better fit: you can keep your documents together, revisit the result, and keep working without starting from scratch.

Jump to detailsOpen in Workspace

Start here

Run this workflow now

Best for a fast one-off run. Add your email, upload the files, and we'll deliver the result without sending you into the full app.

Workflow

Quality Agreement for Contract Manufacturing

Step 1 · Deliver to

Step 3 · Run this workflow

Workflow

Quality Agreement for Contract Manufacturing

Overview

Drafting quality agreements for contract manufacturing requires deep knowledge of cGMP regulations, careful allocation of quality responsibilities, and precise documentation of compliance procedures. Attorneys and regulatory professionals spend 6-8 hours researching FDA requirements, coordinating with quality units, and ensuring every clause meets regulatory standards—time that could be spent on strategic compliance initiatives.

Quality Agreements are critical regulatory documents that define quality responsibilities between product owners and contract manufacturers, but drafting comprehensive agreements that satisfy FDA expectations under 21 CFR Parts 210-211 and ICH Q7 requires deep regulatory expertise. Manual drafting takes 12-20 hours and risks missing critical compliance elements like quality unit independence, change control protocols, or data integrity requirements that FDA inspectors scrutinize.

CaseMark's AI analyzes your manufacturing contracts, product specifications, and regulatory requirements to generate comprehensive Quality Agreements that meet current FDA guidance. The system incorporates best practices from the 2016 FDA Guidance on Contract Manufacturing Arrangements, ensures proper delineation of quality responsibilities, and creates enforceable provisions covering all critical areas from batch release to regulatory inspections.

How it works

  1. 1. Upload your documents

  2. 2. AI analyzes and extracts key information

  3. 3. Review and customize the generated content

  4. 4. Export in your preferred format (DOCX, PDF)

What you get

  • Purpose and Scope

  • Quality Responsibilities

  • Quality Unit Roles

  • Manufacturing Activities and Batch Records

  • Change Control Procedures

  • Audits and Inspections

  • Signature Blocks

What it handles

  • Purpose and Scope

  • Quality Responsibilities

  • Quality Unit Roles

  • Manufacturing Activities and Batch Records

  • Change Control Procedures

  • Audits and Inspections

  • Signature Blocks

Required documents

  • Manufacturing Agreement or Supply Contract

    Underlying commercial agreement between product owner and contract manufacturer that this quality agreement will complement

    PDF, DOCX

  • Product Specifications

    Detailed product specifications, acceptance criteria, and quality attributes for products covered by the agreement

    PDF, DOCX, XLSX

Supporting documents

  • Existing Quality Agreement Template

    Previous quality agreements or company templates to maintain consistency with established practices

    PDF, DOCX

  • FDA Inspection Reports or 483s

    Recent regulatory inspection findings for either party to address known compliance gaps

    PDF

  • Quality System Procedures

    Company-specific SOPs for change control, deviation management, CAPA, or other quality processes

    PDF, DOCX

  • Facility Certifications

    ISO certifications, FDA registration numbers, or other quality management system credentials

    PDF

  • Regulatory Correspondence

    FDA communications, warning letters, or regulatory commitments relevant to the manufacturing relationship

    PDF, DOCX

Why teams use it

Generate FDA-compliant quality agreements in 12 minutes vs. 6+ hours manually

Ensure all cGMP requirements are addressed with AI-guided section completion

Standardize quality responsibility allocation across multiple contract relationships

Reduce regulatory risk with built-in compliance checks for FDA requirements

Eliminate repetitive drafting work and focus on strategic regulatory counsel

Questions

What is a Quality Agreement and why is it required for contract manufacturing?

A Quality Agreement is a regulatory document that defines quality-related roles, responsibilities, and compliance obligations between a product owner and contract manufacturer. While not explicitly required by FDA regulations, the 2016 FDA Guidance for Industry on Contract Manufacturing Arrangements strongly recommends Quality Agreements to clearly delineate quality responsibilities and ensure cGMP compliance. FDA inspectors routinely request these agreements during inspections to verify proper quality oversight of outsourced manufacturing.

How is a Quality Agreement different from a manufacturing or supply agreement?

A Quality Agreement focuses exclusively on quality assurance, regulatory compliance, and cGMP requirements, while manufacturing agreements address commercial terms like pricing, volumes, and delivery schedules. The Quality Agreement establishes that quality decisions take precedence over commercial considerations and defines technical matters like specifications, change control, deviation investigations, and batch release authority. These documents complement each other but serve distinct purposes, with the Quality Agreement ensuring regulatory compliance independent of business pressures.

What are the most critical elements FDA expects in a Quality Agreement?

FDA expects Quality Agreements to clearly define each party's quality unit responsibilities, establish batch release and disposition authority, outline comprehensive change control procedures, specify audit rights and regulatory inspection protocols, and detail procedures for managing deviations and quality events. The agreement must demonstrate quality unit independence from commercial pressures, establish proper documentation and record retention requirements, and ensure both parties understand their regulatory obligations. FDA's 2016 guidance emphasizes that ambiguity in quality responsibilities is a common deficiency.

How often should Quality Agreements be updated or revised?

Quality Agreements should be reviewed at least every two to three years to ensure alignment with current regulatory guidance, industry best practices, and any changes in the manufacturing relationship. They must be updated whenever significant changes occur such as new product additions, facility changes, regulatory requirement updates, or lessons learned from inspections or quality events. The agreement should include provisions for amendment procedures and change control to ensure both parties approve modifications that affect quality responsibilities or compliance obligations.

Who has final authority for batch release in a contract manufacturing relationship?

The product owner's Quality Unit typically retains final batch disposition authority, even when the contract manufacturer performs release testing. This ensures the product owner maintains ultimate accountability for product quality and regulatory compliance. The Quality Agreement should clearly specify that the contract manufacturer may place batches on quality hold and perform initial testing, but final release for distribution requires the product owner's approval based on review of complete batch documentation including manufacturing records, testing results, and deviation assessments.

Related

510k Premarket Notification

Draft FDA 510(k) Submissions in Minutes, Not Hours

Adverse Event Reporting Policy

Draft FDA-Compliant Adverse Event Policies in Minutes

Anti-Money Laundering (AML) Compliance Program

Draft AML Compliance Programs in Minutes, Not Days